Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Liver Neoplasms × Drug Therapy × Clear all

Phase

Phase 2 4 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Lymphoma, Non-Hodgkin 2 Adenocarcinoma 2 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 NSCLC 1 Multiple Myeloma 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 HER-2 Negative Breast Cancer 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Acute Kidney Injury 1

Interventions

Radiofrequency Ablation 3 atezolizumab 2 Sorafenib 2 Dexmedetomidine 2 Bevacizumab 2 voxilaprevir 1 velpatasvir 1 huachansu 1 gadolinium ethoxybenzyl DTPA 1 entecavir 1 Tobacco Use Cessation Devices 1 Telbivudine 1 Technetium Tc 99m Aggregated Albumin 1 Sofosbuvir 1 Sevoflurane 1 Ribavirin 1 Radionuclide Generators 1 Psychiatric Rehabilitation 1 Propofol 1 Pregabalin 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Neuroleptanalgesia 1 Lamivudine 1 Immunotherapy 1 Gene Expression Profiling 1 Galactose 1 Fluorouracil 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡